Searchable abstracts of presentations at key conferences in endocrinology

ea0020p614 | Neuroendocrinology, Pituitary and Behaviour | ECE2009

Plasma thrombin-activatable fibrinolysis inhibitor antigen levels in acromegalic patients

Ozbek Mustafa , Erdogan Mehmet , Ceneli Ozcan , Saltas Hakan , Akbal Erdem , Kizilgun Mustafa , Ureten Kemal

Objective: Acromegaly is associated with increased morbidity and mortality, mostly due to cardiovascular complications. Thrombin-activatable fibrinolysis inhibitor (TAFI) is associated with coagulation/fibrinolysis and inflammation. Plasma TAFI may participate in arterial thrombosis in cardiovascular diseases (CVD). In this study, we aimed to evaluate the levels of TAFI antigen and also its relationship with other markers in a group of patients with acromegaly in compoa...